Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study. (Q51353951)
Jump to navigation
Jump to search
scientific article published in October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study. |
scientific article published in October 2012 |
Statements
1 reference
Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study. (English)
1 reference
G Grunberger
1 reference
A Chang
1 reference
G Garcia Soria
1 reference
F T Botros
1 reference
R Bsharat
1 reference
Z Milicevic
1 reference
1 October 2012
1 reference
1 reference
29
1 reference
1260-1267
1 reference
10
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference